Skip to content
10-Q

Quarterly Report

Telesis Bio Inc.

0000950170-24-122726

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 6, 2024 1.78M sh
Shares Diluted Q3 2024 · Sep 30, 2024 1.77M sh
Shares Diluted Q3 2024 · Sep 30, 2024 1.72M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.66M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.66M sh
Capex Q3 2024 · Sep 30, 2024 $638K
Capex restated Q3 2024 · Sep 30, 2023 $1.63M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$15.54M
Operating Cash Flow restated Q3 2024 · Sep 30, 2023 −$27.34M
Long Term Debt Q3 2024 · Sep 30, 2024 $5.84M
Long Term Debt Q3 2024 · Dec 31, 2023 $5.27M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $3.72M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $1.57M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$27.22M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$20.54M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$8.24M
Stockholders Equity Q3 2024 · Dec 31, 2023 $238K
Stockholders Equity Q3 2024 · Sep 30, 2023 $17.77M
Stockholders Equity Q3 2024 · Jun 30, 2023 $27.92M
Stockholders Equity Q3 2024 · Mar 31, 2023 $36.62M
Stockholders Equity Q3 2024 · Dec 31, 2022 $46.57M
Current Liabilities Q3 2024 · Sep 30, 2024 $6.63M
Current Liabilities Q3 2024 · Dec 31, 2023 $8.18M
Total Liabilities Q3 2024 · Sep 30, 2024 $20.86M
Total Liabilities Q3 2024 · Dec 31, 2023 $40.87M
Current Assets Q3 2024 · Sep 30, 2024 $8.12M
Current Assets Q3 2024 · Dec 31, 2023 $30.35M
Total Assets Q3 2024 · Sep 30, 2024 $24.74M
Total Assets Q3 2024 · Dec 31, 2023 $70.41M
Eps Diluted Q3 2024 · Sep 30, 2024 −$4.09
Eps Diluted Q3 2024 · Sep 30, 2024 −$17.20
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$6.73
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$18.58
Eps Basic Q3 2024 · Sep 30, 2024 −$4.09
Eps Basic Q3 2024 · Sep 30, 2024 −$17.20
Eps Basic restated Q3 2024 · Sep 30, 2023 −$6.73
Eps Basic restated Q3 2024 · Sep 30, 2023 −$18.58
Sga Expense Q3 2024 · Sep 30, 2024 $3.1M
Sga Expense Q3 2024 · Sep 30, 2024 $13.58M
Sga Expense restated Q3 2024 · Sep 30, 2023 $5.88M
Sga Expense restated Q3 2024 · Sep 30, 2023 $16.27M
Rd Expense Q3 2024 · Sep 30, 2024 $2.17M
Rd Expense Q3 2024 · Sep 30, 2024 $7M
Rd Expense restated Q3 2024 · Sep 30, 2023 $3.33M
Rd Expense restated Q3 2024 · Sep 30, 2023 $11.75M
Net Income Q3 2024 · Sep 30, 2024 −$6.64M
Net Income Q3 2024 · Sep 30, 2024 −$27.86M
Net Income Q3 2024 · Jun 30, 2024 −$12.59M
Net Income Q3 2024 · Mar 31, 2024 −$8.64M
Net Income Q3 2024 · Sep 30, 2023 −$10.63M
Net Income Q3 2024 · Sep 30, 2023 −$30.04M
Net Income Q3 2024 · Jun 30, 2023 −$8.29M
Net Income Q3 2024 · Mar 31, 2023 −$11.12M
Operating Income Q3 2024 · Sep 30, 2024 −$5.48M
Operating Income Q3 2024 · Sep 30, 2024 −$24.76M
Operating Income restated Q3 2024 · Sep 30, 2023 −$9.38M
Operating Income restated Q3 2024 · Sep 30, 2023 −$27.31M
Gross Profit Q3 2024 · Sep 30, 2024 $1.01M
Gross Profit Q3 2024 · Sep 30, 2024 $1.32M
Gross Profit restated Q3 2024 · Sep 30, 2023 $2.54M
Gross Profit restated Q3 2024 · Sep 30, 2023 $10.28M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $557K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $3.99M
Cost Of Revenue restated Q3 2024 · Sep 30, 2023 $1.56M
Cost Of Revenue restated Q3 2024 · Sep 30, 2023 $5.5M
Revenue Q3 2024 · Sep 30, 2024 $1.57M
Revenue Q3 2024 · Sep 30, 2024 $5.31M
Revenue restated Q3 2024 · Sep 30, 2023 $4.1M
Revenue restated Q3 2024 · Sep 30, 2023 $15.78M